Respiratory syncytial virus.
Ruuskanen
O
O
Department of Pediatrics, Turku University Hospital, Finland.
Ogra
P L
PL
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000917:Antibody Formation; D002675:Child, Preschool; D006801:Humans; D007111:Immunity, Cellular; D015994:Incidence; D007223:Infant; D015995:Prevalence; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D012307:Risk Factors; D014612:Vaccines; D005719:gamma-Globulins / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000900:Anti-Bacterial Agents; D014612:Vaccines; D005719:gamma-Globulins